LEPONEX Side Effects

6695997-3 | Carcinoembryonic Antigen Increased, Coagulopathy, Haemoglobin Decreased
on Apr 13, 2010 Male patient from GERMANY , 57 years of age, was treated with Leponex (View Usage). Patient experienced the following unwanted or unexpected effects: carcinoembryonic antigen increased, coagulopathy, haemoglobin decreased. Leponex dosage: 225 Mg/day. During the same period patient was treated with DIAZEPAM (1 Tablet To Night) (View Diazepam Review and Diazepam Label ).

6691825-0 | Intraocular Pressure Increased, Vision Blurred
Patient was taking Leponex (View Usage). Patient had the following side effects: intraocular pressure increased, vision blurred on Apr 09, 2010 from GERMANY Additional patient health information: Male patient , 41 years of age, was diagnosed with schizophrenia and. Leponex dosage: 500 Mg/day. During the same period patient was treated with ATOSIL (Drops As Needed) (View Atosil Review and Atosil Label ), ABILIFY (View Abilify Review and Abilify Label ).

6685965-X | Central Obesity, Depression, Increased Appetite, Salivary Hypersecretion, Schizophrenia, Weight Increased
Adverse event was reported on Apr 07, 2010 by a Male patient taking Leponex (View Usage) (Dosage: 25 Mg, Unk) was diagnosed with depression (What is depression?), schizophrenia and. Location: BRAZIL , weighting 198.4 lb, After Leponex was administered, patient had the following side effects: central obesity, depression (What is depression?), increased appetite, salivary hypersecretion, schizophrenia, weight increased. During the same period patient was treated with FLUOXETINE (1 Df, Qd) (View Fluoxetine Review and Fluoxetine Label ), CARBOLITHIUM (1 Df, Tid) (View Carbolithium Review and Carbolithium Label ), DIAZEPAM (1 Df, Qd (1 Tablet In The Morning)) (View Diazepam Review and Diazepam Label ), BIPERIDEN HYDROCHLORIDE (1 Tablet In The Morning) (View Biperiden Hydrochloride Review and Biperiden Hydrochloride Label ).

6684290-0 | Blood Albumin Decreased, C-reactive Protein Increased, Cough, Crohn's Disease, Diarrhoea, Dysphonia, Eosinophil Count Decreased, Infection, Malabsorption
on Apr 01, 2010 Female patient from FINLAND , 73 years of age, was diagnosed with schizophrenia and was treated with Leponex (View Usage). Patient experienced the following unwanted or unexpected effects: blood albumin decreased, c-reactive protein increased, cough, crohn's disease (What is crohn's disease?), diarrhoea, dysphonia, eosinophil count decreased, infection (What is infection?), malabsorption. Leponex dosage: 25 Mg, Once A Day. During the same period patient was treated with ASASANTIN (View Asasantin Review and Asasantin Label ), SIMVASTATIN (10 Mg, A Day) (View Simvastatin Review and Simvastatin Label ), TENOX (TEMAZEPAM) (20 Mg, A Day) (View Tenox (temazepam) Review and Tenox (temazepam) Label ), ABILIFY (15 Mg, A Day) (View Abilify Review and Abilify Label ), CIRCADIN (2 Mg Two Doses A Day) (View Circadin Review and Circadin Label ), MOVICOL (View Movicol Review and Movicol Label ), CEDAX ^ESSEX^ (View Cedax ^essex^ Review and Cedax ^essex^ Label ). Patient was hospitalized.


6682637-2 | Abdominal Pain, Alveolitis, Anti-hbe Antibody Positive, Anti-hbs Antibody Positive, Hyperamylasaemia, Hyperlipasaemia, Lung Disorder, Pancreatitis Acute, Pneumococcal Infection
on Apr 02, 2010 Male patient from FRANCE , 50 years of age, was diagnosed with agitation and was treated with Leponex (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), alveolitis, anti-hbe antibody positive, anti-hbs antibody positive, hyperamylasaemia, hyperlipasaemia, lung disorder, pancreatitis acute, pneumococcal infection. Leponex dosage: 1 Df In Morning And 1.5 Df In The Evening. During the same period patient was treated with LARGACTIL (Unk) (View Largactil Review and Largactil Label ), VALPROATE SODIUM (2 Df In The Morning , At Midday And In The Evening) (View Valproate Sodium Review and Valproate Sodium Label ), HEPT A MYL (2 Df In The Morning , At Midday And In The Evening) (View Hept-a-myl Review and Hept-a-myl Label ), ATARAX (100 Mg 0.5 Df In The Morning And 1 Df In The Evening) (View Atarax Review and Atarax Label ), XANAX (0.5 Df In The Morning And 0.5 Df In The Evening) (View Xanax Review and Xanax Label ), TERCIAN (25, 1df In The Morning , At Midday And In The Evening) (View Tercian Review and Tercian Label ). Patient was hospitalized.

6682585-8 | Arrhythmia, Bacterial Infection, C-reactive Protein Increased, Condition Aggravated, Diarrhoea, Eosinophil Count Increased, Fatigue, Gastroenteritis, Heart Rate Increased
Patient was taking Leponex (View Usage). After Leponex was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), bacterial infection (What is bacterial infection?), c-reactive protein increased, condition aggravated, diarrhoea, eosinophil count increased, fatigue, gastroenteritis (What is gastroenteritis?), heart rate increased on Apr 01, 2010 from FINLAND Additional patient health information: Female patient , 36 years of age, was diagnosed with schizophrenia and. Leponex dosage: 12.5 Mg, Bid. During the same period patient was treated with MOVICOL (One To Two Times A Day) (View Movicol Review and Movicol Label ), SERDOLECT (20 Mg, Qd) (View Serdolect Review and Serdolect Label ), OPAMOX (15 Mg One To Three Times A Day) (View Opamox Review and Opamox Label ). Patient was hospitalized.

6681514-0 | Arrhythmia, Bacterial Infection, C-reactive Protein Increased, Cardiac Failure, Condition Aggravated, Diarrhoea, Eosinophil Count Increased, Fatigue, Gastroenteritis
Adverse event was reported on Apr 01, 2010 by a Female patient taking Leponex (View Usage) (Dosage: 12.5 Mg, Bid) was diagnosed with schizophrenia and. Location: FINLAND , 36 years of age, Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), bacterial infection (What is bacterial infection?), c-reactive protein increased, cardiac failure, condition aggravated, diarrhoea, eosinophil count increased, fatigue, gastroenteritis (What is gastroenteritis?). During the same period patient was treated with MOVICOL (One To Two Times A Day) (View Movicol Review and Movicol Label ), SERDOLECT (20 Mg, Qd) (View Serdolect Review and Serdolect Label ), OPAMOX (15 Mg One To Three Times A Day) (View Opamox Review and Opamox Label ). Patient was hospitalized.

6680798-2 | Blood Albumin Decreased, C-reactive Protein Increased, Cough, Crohn's Disease, Diarrhoea, Dysphonia, Eosinophil Count Decreased, Infection, Malabsorption
on Apr 01, 2010 Female patient from FINLAND , 73 years of age, was diagnosed with schizophrenia and was treated with Leponex (View Usage). Patient had the following side effects: blood albumin decreased, c-reactive protein increased, cough, crohn's disease (What is crohn's disease?), diarrhoea, dysphonia, eosinophil count decreased, infection (What is infection?), malabsorption. Leponex dosage: 25 Mg, Once A Day. During the same period patient was treated with ASASANTIN (View Asasantin Review and Asasantin Label ), SIMVASTATIN (10 Mg, A Day) (View Simvastatin Review and Simvastatin Label ), TENOX (TEMAZEPAM) (20 Mg, A Day) (View Tenox (temazepam) Review and Tenox (temazepam) Label ), ABILIFY (15 Mg, A Day) (View Abilify Review and Abilify Label ), CIRCADIN (2 Mg Two Doses A Day) (View Circadin Review and Circadin Label ), MOVICOL (View Movicol Review and Movicol Label ), CEDAX ^ESSEX^ (View Cedax ^essex^ Review and Cedax ^essex^ Label ). Patient was hospitalized.

6676641-8 | Dental Caries, Gingival Recession, Gingivitis
on Apr 01, 2010 Female patient from GERMANY , weighting 198.4 lb, was diagnosed with schizophrenia, paranoid type and was treated with Leponex (View Usage). After Leponex was administered, patient had the following side effects: dental caries, gingival recession, gingivitis. Leponex dosage: 800 Mg/day. During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), HALDOL (View Haldol Review and Haldol Label ).

6653364-2 | Coagulopathy, Haemoglobin Decreased
Patient was taking Leponex (View Usage). Patient experienced the following unwanted or unexpected effects: coagulopathy, haemoglobin decreased on Mar 15, 2010 from GERMANY Additional patient health information: Male patient , 57 years of age, . Leponex dosage: 225 Mg/day. During the same period patient was treated with DIAZEPAM (1 Tablet To Night) (View Diazepam Review and Diazepam Label ).

6648094-7 | Aggression, Disease Progression, Haemorrhage, Tendon Injury
Adverse event was reported on Mar 22, 2010 by a Male patient taking Leponex (View Usage) (Dosage: 1 Tablet In The Morning, 1 Tablet At Noon And 1.5 Tablet At Night) was diagnosed with schizophrenia and. Location: BRAZIL , 31 years of age, weighting 231.5 lb, Patient had the following side effects: aggression, disease progression, haemorrhage, tendon injury. Patient was hospitalized.

6644107-7 | Incorrect Dose Administered, Psychiatric Symptom
on Mar 10, 2010 Female patient from BRAZIL , 69 years of age, was diagnosed with schizophrenia and was treated with Leponex (View Usage). After Leponex was administered, patient had the following side effects: incorrect dose administered, psychiatric symptom. Leponex dosage: 1 Tablet (25 Mg) At Night.

6641937-2 | Cardiomegaly, Mitral Valve Incompetence
on Mar 08, 2010 Male patient from GERMANY , 41 years of age, was diagnosed with schizophrenia, paranoid type and was treated with Leponex (View Usage). Patient experienced the following unwanted or unexpected effects: cardiomegaly, mitral valve incompetence. Leponex dosage: 350 Mg/day.

6641930-X | Aspiration, Depressed Level Of Consciousness, Electrocardiogram Qt Prolonged, Intentional Overdose, Metabolic Acidosis, Ph Body Fluid Increased, Respiratory Depression, Suicide Attempt, Vomiting
Patient was taking Leponex (View Usage). Patient had the following side effects: aspiration, depressed level of consciousness, electrocardiogram qt prolonged, intentional overdose, metabolic acidosis, ph body fluid increased, respiratory depression, suicide attempt, vomiting on Mar 08, 2010 from SWITZERLAND Additional patient health information: Female patient , 61 years of age, . Leponex dosage: Unk. During the same period patient was treated with ORFIRIL (Maximum 30 G) (View Orfiril Review and Orfiril Label ). Patient was hospitalized.

6639767-0 | Arterial Occlusive Disease, Arteriosclerosis, Aspiration Bronchial, Cerebrovascular Accident, Coma Scale Abnormal, Coronary Artery Embolism, Hemianopia, Hemiparesis, Myocardial Infarction
Adverse event was reported on Mar 12, 2010 by a Female patient taking Leponex (View Usage) (Dosage: 25 Mg/day) was diagnosed with acute psychosis and. Location: SWITZERLAND , 84 years of age, After Leponex was administered, patient had the following side effects: arterial occlusive disease, arteriosclerosis, aspiration bronchial, cerebrovascular accident, coma scale abnormal, coronary artery embolism, hemianopia, hemiparesis, myocardial infarction. During the same period patient was treated with RISPERDAL (3 Mg/d) (View Risperdal Review and Risperdal Label ), SOLIAN (400 Mg/day) (View Solian Review and Solian Label ), CITALOPRAM HYDROBROMIDE (20 Mg/day) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), VESICARE (5 Mg/d) (View Vesicare Review and Vesicare Label ), DISTRANEURIN (300 Mg/d) (View Distraneurin Review and Distraneurin Label ), LAXOBERON (20 Goutes/day) (View Laxoberon Review and Laxoberon Label ), DAFALGAN (3000 Mg/d) (View Dafalgan Review and Dafalgan Label ), NEXIUM (20 Mg/d) (View Nexium Review and Nexium Label ). Patient was hospitalized.

6631493-7 | Back Pain, Erectile Dysfunction, Fistula, Penile Pain, Priapism, Scrotal Pain, Therapeutic Procedure
on Mar 01, 2010 Male patient from BRAZIL , 34 years of age, weighting 233.7 lb, was diagnosed with schizophrenia, depression (What is depression?) and was treated with Leponex (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), erectile dysfunction (What is erectile dysfunction?), fistula (What is fistula?), penile pain, priapism, scrotal pain, therapeutic procedure. Leponex dosage: 1 Df, Qhs. During the same period patient was treated with GEODON (2 Df, Qhs) (View Geodon Review and Geodon Label ). Patient was hospitalized.

6617761-3 | Infertility Male, Sperm Count Decreased, Spermatozoa Progressive Motility Decreased
on Feb 26, 2010 Male patient from GERMANY , 26 years of age, was treated with Leponex (View Usage). Patient had the following side effects: infertility male, sperm count decreased, spermatozoa progressive motility decreased. Leponex dosage: 150 Mg In Evening.

6616200-6 | Electroencephalogram Abnormal, Myoclonic Epilepsy
Patient was taking Leponex (View Usage). After Leponex was administered, patient had the following side effects: electroencephalogram abnormal, myoclonic epilepsy on Feb 26, 2010 from GERMANY Additional patient health information: Male patient , 30 years of age, . Leponex dosage: 600 Mg, Qd. During the same period patient was treated with DIAZEPAM (8 To 5 Mg Per Day) (View Diazepam Review and Diazepam Label ), HALOPERIDOL (10 Mg Per Day) (View Haloperidol Review and Haloperidol Label ).

6613333-5 | Acute Hepatic Failure, Back Pain, Cerebral Haemorrhage, Coma Hepatic, Constipation, Convulsion, Dizziness, Hepatocellular Injury, Infection
Adverse event was reported on Feb 25, 2010 by a Female patient taking Leponex (View Usage) (Dosage: Unk) was diagnosed with psychotic disorder (What is psychotic disorder?), urinary tract infection (What is urinary tract infection?), oral contraception, depression (What is depression?) and. Location: DENMARK , weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: acute hepatic failure, back pain (What is back pain?), cerebral haemorrhage, coma hepatic, constipation (What is constipation?), convulsion, dizziness (What is dizziness?), hepatocellular injury, infection (What is infection?). During the same period patient was treated with NITROFURANTOIN (50 Mg, Qd) (View Nitrofurantoin Review and Nitrofurantoin Label ), DIANE MITE (1 Df, Qd) (View Diane Mite Review and Diane Mite Label ), TRUXAL (50 Mg, Prn) (View Truxal Review and Truxal Label ), ZOLADEX (View Zoladex Review and Zoladex Label ), CISORDINOL (View Cisordinol Review and Cisordinol Label ), RISPERDAL (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

6603072-9 |
on Feb 19, 2010 Female patient from DENMARK , weighting 188.1 lb, was diagnosed with mental disorder, salivary hypersecretion, laxative supportive care and was treated with Leponex (View Usage). . Leponex dosage: 800 Mg/day. During the same period patient was treated with ERYTHROMYCIN (500 Mg, Qd) (View Erythromycin Review and Erythromycin Label ), RISPERIDONE (8 Mg/day) (View Risperidone Review and Risperidone Label ), LYSANTIN (100 Mg/day) (View Lysantin Review and Lysantin Label ), RIVOTRIL (2 Mg, Qd) (View Rivotril Review and Rivotril Label ), ZUCLOPENTHIXOL (20 Mg, Qd) (View Zuclopenthixol Review and Zuclopenthixol Label ), IMIPRAMINE (100 Mg, Qd) (View Imipramine Review and Imipramine Label ), TRUXAL (Prn) (View Truxal Review and Truxal Label ), ACTILAX (15 Drops, Unk) (View Actilax Review and Actilax Label ).

6594552-3 | Eosinophilia, Neutrophil Count Decreased, Thrombocytopenia
on Feb 11, 2010 Female patient from FINLAND , 57 years of age, was treated with Leponex (View Usage). After Leponex was administered, patient had the following side effects: eosinophilia, neutrophil count decreased, thrombocytopenia. Leponex dosage: 50 Mg + 50 Mg + 150 Mg.

6590099-9 | Athetosis, Cogwheel Rigidity, Dyskinesia, Epilepsy, Infection, Overdose, Suicide Attempt, Transaminases Increased, White Blood Cell Count Increased
Patient was taking Leponex (View Usage). Patient experienced the following unwanted or unexpected effects: athetosis, cogwheel rigidity, dyskinesia, epilepsy (What is epilepsy?), infection (What is infection?), overdose, suicide attempt, transaminases increased, white blood cell count increased on Feb 17, 2010 from YUGOSLAVIA Additional patient health information: Female patient , 26 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?) and. Leponex dosage: 100 Mg Unk. During the same period patient was treated with MENDILEX (View Mendilex Review and Mendilex Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), OPRAZOLAM (View Oprazolam Review and Oprazolam Label ), CAVINTON (View Cavinton Review and Cavinton Label ), TANAKAN (View Tanakan Review and Tanakan Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ). Patient was hospitalized.

6589970-3 | Psychotic Disorder
Adverse event was reported on Feb 08, 2010 by a Male patient taking Leponex (View Usage) (Dosage: 300 Mg, Unk) . Location: GERMANY , weighting 270.1 lb, Patient had the following side effects: psychotic disorder (What is psychotic disorder?). Patient was hospitalized.

6589968-5 | Psychotic Disorder
on Feb 08, 2010 Male patient from GERMANY , weighting 270.1 lb, was treated with Leponex (View Usage). After Leponex was administered, patient had the following side effects: psychotic disorder (What is psychotic disorder?). Leponex dosage: 300 Mg, Unk. Patient was hospitalized.

6583494-5 | Coma, Disorientation
on Feb 03, 2010 Female patient from SWITZERLAND , 80 years of age, was diagnosed with psychomotor hyperactivity and was treated with Leponex (View Usage). Patient experienced the following unwanted or unexpected effects: coma, disorientation. Leponex dosage: 62.5 Mg/day. During the same period patient was treated with BUSPAR (10 Mg/day) (View Buspar Review and Buspar Label ). Patient was hospitalized.

6574707-4 | Blood Culture Positive, Cardiac Failure, Hyperpyrexia, Leukocytosis, Myocarditis, Troponin Increased
Patient was taking Leponex (View Usage). Patient had the following side effects: blood culture positive, cardiac failure, hyperpyrexia, leukocytosis, myocarditis, troponin increased on Jan 29, 2010 from ITALY Additional patient health information: Male patient , 32 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?) and. Leponex dosage: 25 Mg/die. During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), NOZINAN (View Nozinan Review and Nozinan Label ), TAVOR (2 Mg, Unk) (View Tavor Review and Tavor Label ). Patient was hospitalized.

6571678-1 | Athetosis, Cogwheel Rigidity, Dyskinesia, Epilepsy, Infection, Overdose, Suicide Attempt, Transaminases Increased, White Blood Cell Count Increased
Adverse event was reported on Feb 02, 2010 by a Female patient taking Leponex (View Usage) (Dosage: 100 Mg Unk) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: SERBIA , 26 years of age, After Leponex was administered, patient had the following side effects: athetosis, cogwheel rigidity, dyskinesia, epilepsy (What is epilepsy?), infection (What is infection?), overdose, suicide attempt, transaminases increased, white blood cell count increased. During the same period patient was treated with MENDILEX (View Mendilex Review and Mendilex Label ), LAMOTRIGINE (View Lamotrigine Review and Lamotrigine Label ), OPRAZOLAM (View Oprazolam Review and Oprazolam Label ), CAVINTON (View Cavinton Review and Cavinton Label ), TANAKAN (View Tanakan Review and Tanakan Label ), VITAMIN B6 (View Vitamin B6 Review and Vitamin B6 Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ). Patient was hospitalized.

6567877-5 | Cerebral Infarction, Confusional State, Haematoma, Haemorrhagic Disorder, Injury, Optic Neuritis, Subdural Effusion, Visual Field Defect
on Jan 20, 2010 Female patient from AUSTRIA , 38 years of age, was treated with Leponex (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction, confusional state, haematoma, haemorrhagic disorder, injury, optic neuritis, subdural effusion, visual field defect. Leponex dosage: Unk. During the same period patient was treated with DEPAKENE (800 Mg, Unk) (View Depakene Review and Depakene Label ), SEROQUEL (300 Mg, Unk) (View Seroquel Review and Seroquel Label ). Patient was hospitalized.

6567581-3 |
on Oct 13, 2009 Female patient from DENMARK , weighting 188.1 lb, was diagnosed with mental disorder, salivary hypersecretion, laxative supportive care and was treated with Leponex (View Usage). . Leponex dosage: 800 Mg/day. During the same period patient was treated with ERYTHROMYCIN (500 Mg, Qd) (View Erythromycin Review and Erythromycin Label ), RISPERIDONE (8 Mg/day) (View Risperidone Review and Risperidone Label ), LYSANTIN (100 Mg/day) (View Lysantin Review and Lysantin Label ), RIVOTRIL (2 Mg, Qd) (View Rivotril Review and Rivotril Label ), ZUCLOPENTHIXOL (20 Mg, Qd) (View Zuclopenthixol Review and Zuclopenthixol Label ), IMIPRAMINE (100 Mg, Qd) (View Imipramine Review and Imipramine Label ), TRUXAL (Prn) (View Truxal Review and Truxal Label ), ACTILAX (15 Drops, Unk) (View Actilax Review and Actilax Label ).

6564553-X | Central Obesity, Depression, Increased Appetite, Salivary Hypersecretion, Schizophrenia, Weight Increased
Patient was taking Leponex (View Usage). After Leponex was administered, patient had the following side effects: central obesity, depression (What is depression?), increased appetite, salivary hypersecretion, schizophrenia, weight increased on Jan 18, 2010 from BRAZIL Additional patient health information: Male patient , weighting 198.4 lb, was diagnosed with depression (What is depression?), schizophrenia and. Leponex dosage: 25 Mg, Unk. During the same period patient was treated with FLUOXETINE (1 Df, Qd) (View Fluoxetine Review and Fluoxetine Label ), CARBOLITHIUM (1 Df, Tid) (View Carbolithium Review and Carbolithium Label ), DIAZEPAM (1 Df, Qd (1 Tablet In The Morning)) (View Diazepam Review and Diazepam Label ), BIPERIDEN HYDROCHLORIDE (1 Tablet In The Morning) (View Biperiden Hydrochloride Review and Biperiden Hydrochloride Label ).

6555653-9 | Blood Albumin Decreased, C-reactive Protein Increased, Diarrhoea, Eosinophil Count Decreased, Infection, Malabsorption, Pyelonephritis, Pyrexia, Respiratory Disorder
Adverse event was reported on Jan 15, 2010 by a Female patient taking Leponex (View Usage) (Dosage: 200 Mg, Qd) was diagnosed with schizophrenia and. Location: FINLAND , 73 years of age, Patient experienced the following unwanted or unexpected effects: blood albumin decreased, c-reactive protein increased, diarrhoea, eosinophil count decreased, infection (What is infection?), malabsorption, pyelonephritis, pyrexia, respiratory disorder. Patient was hospitalized.

6549366-7 | Anhedonia, Apathy, Asocial Behaviour, Cognitive Disorder, Crying, Depression, Gait Disturbance
on Jan 14, 2010 Male patient from SWITZERLAND , 81 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and was treated with Leponex (View Usage). Patient had the following side effects: anhedonia, apathy, asocial behaviour, cognitive disorder, crying, depression (What is depression?), gait disturbance. Leponex dosage: 25 Mg/day. During the same period patient was treated with DEPAKENE (1500 Mg/day) (View Depakene Review and Depakene Label ).

6549341-2 | Blood Albumin Decreased, C-reactive Protein Increased, Diarrhoea, Infection, Malabsorption, Pyelonephritis, Pyrexia, Respiratory Disorder
on Jan 12, 2010 Female patient from FINLAND , 73 years of age, was diagnosed with schizophrenia and was treated with Leponex (View Usage). After Leponex was administered, patient had the following side effects: blood albumin decreased, c-reactive protein increased, diarrhoea, infection (What is infection?), malabsorption, pyelonephritis, pyrexia, respiratory disorder. Leponex dosage: 200 Mg, Qd. Patient was hospitalized.

6544639-6 | Cardiac Arrest, Cardiogenic Shock, Hypotension, Malaise, Pulmonary Embolism
Patient was taking Leponex (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), cardiogenic shock, hypotension, malaise, pulmonary embolism (What is pulmonary embolism?) on Jan 18, 2010 from FRANCE Additional patient health information: Male patient , 48 years of age, was diagnosed with schizophrenia, paranoid type and. Leponex dosage: Unk. During the same period patient was treated with LEPTICUR (3 Df, Qd) (View Lepticur Review and Lepticur Label ), STILNOX (1 Df, Unk) (View Stilnox Review and Stilnox Label ), SULFARLEM (3 Df, Qd) (View Sulfarlem Review and Sulfarlem Label ), TERCIAN (15 Mg, Qd) (View Tercian Review and Tercian Label ), VALIUM (5 Mg, Qd) (View Valium Review and Valium Label ).

6543071-9 | Confusional State, Speech Disorder
Adverse event was reported on Jan 07, 2010 by a Female patient taking Leponex (View Usage) (Dosage: 250 Mg, Qd) was diagnosed with mental disorder and. Location: FRANCE , 57 years of age, Patient had the following side effects: confusional state, speech disorder. During the same period patient was treated with IMOVANE (Unk) (View Imovane Review and Imovane Label ), RIVOTRIL (Unk) (View Rivotril Review and Rivotril Label ).

6541838-4 | Completed Suicide
on Jan 14, 2010 Male patient from GERMANY , weighting 176.4 lb, was diagnosed with psychotic disorder (What is psychotic disorder?) and was treated with Leponex (View Usage). After Leponex was administered, patient had the following side effects: completed suicide. Leponex dosage: Unk.

6539994-7 | Anxiety, Bundle Branch Block, Delirium, Hypotension, Sinus Tachycardia
on Jan 08, 2010 Male patient from FRANCE , weighting 163.1 lb, was diagnosed with schizophrenia and was treated with Leponex (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), bundle branch block, delirium, hypotension, sinus tachycardia. Leponex dosage: 200 Mg Daily. During the same period patient was treated with PRAZEPAM (View Prazepam Review and Prazepam Label ), TERCIAN (View Tercian Review and Tercian Label ), IMOVANE (View Imovane Review and Imovane Label ). Patient was hospitalized.

6539057-0 | Vision Blurred
Patient was taking Leponex (View Usage). Patient had the following side effects: vision blurred on Jan 05, 2010 from FINLAND Additional patient health information: Male patient , 17 years of age, was diagnosed with schizophrenia, paranoid type and. Leponex dosage: 300 Mg/day.

6529313-4 | Neutropenia
Adverse event was reported on Dec 31, 2009 by a Female patient taking Leponex (View Usage) (Dosage: 250 Mg/day) was diagnosed with schizophrenia and. Location: FINLAND , 48 years of age, After Leponex was administered, patient had the following side effects: neutropenia.

6523618-9 | Asphyxia, Cardio-respiratory Distress, Constipation, Nausea, Overdose
on Dec 28, 2009 Male patient from FRANCE , 37 years of age, was treated with Leponex (View Usage). Patient experienced the following unwanted or unexpected effects: asphyxia, cardio-respiratory distress, constipation (What is constipation?), nausea (What is nausea?), overdose. Leponex dosage: 300 Mg Daily. During the same period patient was treated with LAROXYL (50 Mg Daily) (View Laroxyl Review and Laroxyl Label ), NOZINAN (100 Drops Daily) (View Nozinan Review and Nozinan Label ), RIVOTRIL (10 Drp, Prn) (View Rivotril Review and Rivotril Label ), ESPERAL (1 Df, Qd) (View Esperal Review and Esperal Label ), DEPAKINE CHRONO (4 Dfdaily) (View Depakine Chrono Review and Depakine Chrono Label ), URBANYL (3 Df Daily) (View Urbanyl Review and Urbanyl Label ), VALIUM (10 Mg, Prn) (View Valium Review and Valium Label ), ESOMEPRAZOLE SODIUM (NEXIUM) (1 Df Daily) (View Esomeprazole Sodium (nexium) Review and Esomeprazole Sodium (nexium) Label ).

6523503-2 | Fall, Lower Limb Fracture, Osteoporosis
on Dec 21, 2009 Female patient from SLOVENIA , 30 years of age, was treated with Leponex (View Usage). Patient had the following side effects: fall (What is fall?), lower limb fracture, osteoporosis (What is osteoporosis?). Leponex dosage: 500 Mg, Daily. During the same period patient was treated with ASENTRA (View Asentra Review and Asentra Label ). Patient was hospitalized.

6521606-X | Parkinson's Disease
Patient was taking Leponex (View Usage). After Leponex was administered, patient had the following side effects: parkinson's disease (What is parkinson's disease?) on Dec 17, 2009 from CHILE Additional patient health information: Female patient , 47 years of age, was diagnosed with schizophrenia and. Leponex dosage: 250 Mg/ Day.

6518708-0 | Blood Pressure Increased, Dizziness, Headache, Sinus Tachycardia
Adverse event was reported on Dec 17, 2009 by a Male patient taking Leponex (View Usage) (Dosage: 450 Mg/day) was diagnosed with schizophrenia and. Location: FRANCE , 30 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure increased, dizziness (What is dizziness?), headache (What is headache?), sinus tachycardia. During the same period patient was treated with STILNOX (View Stilnox Review and Stilnox Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ), TRANSIPEG (View Transipeg Review and Transipeg Label ), LEPTICUR (View Lepticur Review and Lepticur Label ).

6511828-6 | Accidental Exposure, Somnolence
on Dec 09, 2009 Male patient from BRAZIL , child 3 years of age, was treated with Leponex (View Usage). Patient had the following side effects: accidental exposure, somnolence. Leponex dosage: 3 Tablets.

6507226-1 | Agitation, Constipation, Dizziness, Fear Of Falling, Nausea, Salivary Hypersecretion, Somnolence, Tremor
on Dec 14, 2009 Female patient from BRAZIL , 44 years of age, weighting 132.3 lb, was diagnosed with schizophrenia, paranoid type and was treated with Leponex (View Usage). After Leponex was administered, patient had the following side effects: agitation, constipation (What is constipation?), dizziness (What is dizziness?), fear of falling, nausea (What is nausea?), salivary hypersecretion, somnolence, tremor. Leponex dosage: 12.5 Mg. During the same period patient was treated with CLONAZEPAM (Between 1 To 3 Tablets Daily) (View Clonazepam Review and Clonazepam Label ), NEOZINE (1 Tablet Daily) (View Neozine Review and Neozine Label ).

6507223-6 | Aggression, Disease Progression, Haemorrhage, Tendon Injury
Patient was taking Leponex (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, disease progression, haemorrhage, tendon injury on Dec 14, 2009 from BRAZIL Additional patient health information: Male patient , 31 years of age, weighting 231.5 lb, was diagnosed with schizophrenia and. Leponex dosage: 1 Tablet In The Morning, 1 Tablet At Noon And 1.5 Tablet At Night. Patient was hospitalized.

6505103-3 | Cystitis Interstitial, Dysuria, Haematuria
Adverse event was reported on Dec 07, 2009 by a Male patient taking Leponex (View Usage) (Dosage: 150 Mg/day) was diagnosed with schizophrenia and. Location: GERMANY , weighting 194.0 lb, Patient had the following side effects: cystitis interstitial, dysuria, haematuria.

6490050-6 | Aggression, Delirium, Eosinophilia, Extrapyramidal Disorder, Fall, Frequent Bowel Movements, Hallucination, Lice Infestation
on Nov 30, 2009 Female patient from BRAZIL , 38 years of age, was diagnosed with schizophrenia and was treated with Leponex (View Usage). After Leponex was administered, patient had the following side effects: aggression, delirium, eosinophilia, extrapyramidal disorder, fall (What is fall?), frequent bowel movements, hallucination, lice infestation. Leponex dosage: 25 Mg/day. During the same period patient was treated with RISPERIDONE (4 Or 6 Mg Daily) (View Risperidone Review and Risperidone Label ).

6489967-8 | Confusional State, Hypotonia, Orthostatic Hypotension
on Nov 30, 2009 Male patient from SERBIA , 44 years of age, was diagnosed with schizoaffective disorder and was treated with Leponex (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, hypotonia, orthostatic hypotension. Leponex dosage: 300 Mg, Daily. During the same period patient was treated with VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), HALDOL (View Haldol Review and Haldol Label ). Patient was hospitalized.

6489960-5 | Dysphagia, Pharyngeal Disorder, Salivary Hypersecretion
Patient was taking Leponex (View Usage). Patient had the following side effects: dysphagia, pharyngeal disorder, salivary hypersecretion on Nov 30, 2009 from SERBIA Additional patient health information: Male patient , 35 years of age, was diagnosed with schizophrenia and. Leponex dosage: 75 Mg/day. During the same period patient was treated with VALPROIC ACID (Unk) (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.